Evidence map›Paper›PMID 24651442›Full record

ArticleCell death & disease2014

Heme oxygenase-1 derived carbon monoxide permits maturation of myeloid cells.

B Wegiel, A Hedblom, M Li, D Gallo, E Csizmadia, C Harris, Z Nemeth, B S Zuckerbraun, M Soares, J L Persson and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Splenic Ly6CBasic research in cardiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

B WegielDepartment of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
A Hedblom1] Department of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA [2] Division of Experimental Cancer Research, Department of Laboratory Medicine, Lund University, Malmo, Sweden.
M LiDepartment of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
D GalloDepartment of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
E CsizmadiaDepartment of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
C HarrisDepartment of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Z NemethDepartment of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
B S ZuckerbraunInflammation Laboratory, Instituto Gulbenkian de Ciência, Oeiras, Portugal.
M SoaresDepartment of Surgery, Gulbenkian Institute, Lisbon, Portugal.
J L PerssonDivision of Experimental Cancer Research, Department of Laboratory Medicine, Lund University, Malmo, Sweden.
L E OtterbeinDepartment of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Beth Israel Deaconess Medical Center · USInstituto Gulbenkian de Ciência · PTLund University · SE

Funding

SHORT-TERM TRAINING: STUDENTS IN PROFESSIONAL SCHOOLST35HL007616 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI RUDOLPH L LEIBEL, Markus Y Mapara · 1985 to 2026
$4.4M
Heme Oxygenase Enzymes/Carbon Monoxide in Hepatic Dysfunction from hemorrhageR01GM082830 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZUCKERBRAUN, BRIAN SCOTT · 2010 to 2014
$1.5M
Anti-Inflammatory Effects of Carbon Monoxide in the LungR01HL071797 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OTTERBEIN, LEO E · 2003 to 2006
$1.3M
Heme degradation pathway and immunomodulation in prostate cancer.R21CA169904 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WEGIEL, BARBARA · 2013 to 2014
$411k
NCI NIH HHS R21 CA169904NCI NIH HHS R21CA169904NHLBI NIH HHS HL-071797NHLBI NIH HHS HL-07616NHLBI NIH HHS R01 HL071797NHLBI NIH HHS T35 HL007616NIGMS NIH HHS R01 GM082830
6 · The paper itself

Abstract

Critical functions of the immune system are maintained by the ability of myeloid progenitors to differentiate and mature into macrophages. We hypothesized that the cytoprotective gas molecule carbon monoxide (CO), generated endogenously by heme oxygenases (HO), promotes differentiation of progenitors into functional macrophages. Deletion of HO-1, specifically in the myeloid lineage (Lyz-Cre:Hmox1(flfl)), attenuated the ability of myeloid progenitors to differentiate toward macrophages and decreased the expression of macrophage markers, CD14 and macrophage colony-stimulating factor receptor (MCSFR). We showed that HO-1 and CO induced CD14 expression and efficiently increased expansion and differentiation of myeloid cells into macrophages. Further, CO sensitized myeloid cells to treatment with MCSF at low doses by increasing MCSFR expression, mediated partially through a PI3K-Akt-dependent mechanism. Exposure of mice to CO in a model of marginal bone marrow transplantation significantly improved donor myeloid cell engraftment efficiency, expansion and differentiation, which corresponded to increased serum levels of GM-CSF, IL-1α and MCP-1. Collectively, we conclude that HO-1 and CO in part are critical for myeloid cell differentiation. CO may prove to be a novel therapeutic agent to improve functional recovery of bone marrow cells in patients undergoing irradiation, chemotherapy and/or bone marrow transplantation.

Indexed as

AnimalsBone Marrow TransplantationCarbon MonoxideCell DifferentiationCell LineageCell ProliferationChemokine CCL2GasesGranulocyte-Macrophage Colony-Stimulating FactorHeme Oxygenase-1HumansInterleukin-1alphaLipopolysaccharide ReceptorsMacrophage Colony-Stimulating FactorMacrophagesMembrane ProteinsCarbon MonoxideCcl2 protein, mouseChemokine CCL2GasesGranulocyte-Macrophage Colony-Stimulating FactorHeme Oxygenase-1Hmox1 protein, mouseInterleukin-1alphaLipopolysaccharide ReceptorsMacrophage Colony-Stimulating FactorMembrane ProteinsPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktReceptor, Macrophage Colony-Stimulating Factor

Identifiers

PMID24651442
PMCPMC3973235
OpenAlexW2109360536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.